133 related articles for article (PubMed ID: 8272147)
1. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
[TBL] [Abstract][Full Text] [Related]
2. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.
Kára J; Zimakova NI; Serebryakova EA; Dĕdková V; Zolotaryov AE
J Cancer Res Clin Oncol; 1994; 120(11):662-7. PubMed ID: 7962042
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
Mikhaevich IS; Vlasenkova NK; Gerasimova GK
Biomed Sci; 1991; 2(6):659-64. PubMed ID: 1841636
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of complexes of platinum (II) with plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
Mikhaevich IS; Vlasenkova NK; Gerasimova GK
Anticancer Drugs; 1992 Oct; 3(5):513-7. PubMed ID: 1450446
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C by semisynthetic phospholipid plasmanyl-(N-acyl)-ethanolamine, a nontoxic antitumor preparation.
Mikhaevich IS; Gerasimova GK; Kára J
Biochem Int; 1991 Jan; 23(2):215-20. PubMed ID: 1859429
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Atassi G; Berlion M; el Oche Y; Bizzari JP
Anticancer Res; 1991; 11(2):975-80. PubMed ID: 2064354
[TBL] [Abstract][Full Text] [Related]
8. The effects of ketoconazole on the human fibrosarcoma cell line HT-1080.
Shaughnessey EA; Walker MJ; Das Gupta TK
Anticancer Res; 1994; 14(2A):513-6. PubMed ID: 8017855
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
[TBL] [Abstract][Full Text] [Related]
10. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a piperidine phospholipid.
Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
[TBL] [Abstract][Full Text] [Related]
13. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo.
Glasgow LA; Crane JL; Kern ER; Youngner JS
Cancer Treat Rep; 1978 Nov; 62(11):1881-8. PubMed ID: 282006
[TBL] [Abstract][Full Text] [Related]
15. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic activities and cytotoxicity of 1-acyl and 1,2-diacyl-1,2,4-triazolidine-3,5-diones in murine and human tissue culture cells.
Hall IH; Wong OT; Simlot R; Miller MC; Izydore RA
Anticancer Res; 1992; 12(5):1355-61. PubMed ID: 1444191
[TBL] [Abstract][Full Text] [Related]
19. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
20. Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.
Gasparri A; Moro M; Curnis F; Sacchi A; Pagano S; Veglia F; Casorati G; Siccardi AG; Dellabona P; Corti A
Cancer Res; 1999 Jun; 59(12):2917-23. PubMed ID: 10383155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
